An article published by Merlin researchers from UNIPD has recently been published in the “Leukemia” journal. The piece is entitled “Mouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1” (Author(s): Zanotti L, Angioni R, Calì B, Soldani C, Ploia C, Moalli F, Gargesha M, D’Amico G, Elliman S, Tedeschi G, Maffioli E, Negri A, Zacchigna S, Sarukhan A, Stein JV, Viola A) and appears in the May issue. The article deals with the impact of MSC on immunity and inflammation and identifies TIMP-1 as a novel biomarker for MSC-based therapy. You can access the article here.
- Queen's University Belfast presentation on MSC therapy, COPD and cystic fibrosis: t.co/5323mFhncB Time ago 13 Days via Hootsuite
- Merlin article on optimisation of MSC now available on line (open access), lead author Samantha de Witte EMC. See t.co/2LWa8WOnjV Time ago 14 Days via Hootsuite
- New article in Hepatology Communications identifies inflammatory cell types with a role in liver disease. For more: t.co/lWAJLddtki Time ago 20 Days via Hootsuite
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.